Namkung Yoon, Sibley David R
Molecular Neuropharmacology Section, NINDS, National Institutes of Health, Bethesda, Maryland 20892-1406, USA.
J Biol Chem. 2004 Nov 19;279(47):49533-41. doi: 10.1074/jbc.M408319200. Epub 2004 Sep 3.
Previously, D2 dopamine receptors (D2 DARs) have been shown to undergo G-protein-coupled receptor kinase phosphorylation in an agonist-specific fashion. We have now investigated the ability of the second messenger-activated protein kinases, protein kinase A (PKA) and protein kinase C (PKC), to mediate phosphorylation and desensitization of the D2 DAR. HEK293T cells were transiently transfected with the D2 DAR and then treated with intracellular activators and inhibitors of PKA or PKC. Treatment with agents that increase cAMP, and activate PKA, had no effect on the phosphorylation state of the D2 DAR, suggesting that PKA does not phosphorylate the D2 DAR in HEK293T cells. In contrast, cellular treatment with phorbol 12-myristate 13-acetate (PMA), a PKC activator, resulted in an approximately 3-fold increase in D2 DAR phosphorylation. The phosphorylation was specific for PKC as the PMA effect was mimicked by phorbol 12,13-dibutyrate, but not by 4alpha-phorbol 12,13-didecanoate, active and inactive, phorbol diesters, respectively. The PMA-mediated D2 DAR phosphorylation was completely blocked by co-treatment with the PKC inhibitor, bisindolylmaleimide II, and augmented by co-transfection with PKCbetaI. In contrast, PKC inhibition had no effect on agonist-promoted phosphorylation, suggesting that PKC is not involved in this response. PKC phosphorylation of the D2 DAR was found to promote receptor desensitization as reflected by a decrease in agonist potency for inhibiting cAMP accumulation. Most interestingly, PKC phosphorylation also promoted internalization of the D2 DAR through a beta-arrestin- and dynamin-dependent pathway, a response not usually associated with PKC phosphorylation of G-protein-coupled receptors. Site-directed mutagenesis experiments resulted in the identification of two domains of PKC phosphorylation sites within the third intracellular loop of the receptor. Both of these domains are involved in regulating sequestration of the D2 DAR, whereas only one domain is involved in receptor desensitization. These results indicate that PKC can mediate phosphorylation of the D2 DAR, resulting in both functional desensitization and receptor internalization.
此前已表明,D2多巴胺受体(D2 DARs)会以激动剂特异性方式发生G蛋白偶联受体激酶磷酸化。我们现在研究了第二信使激活的蛋白激酶,蛋白激酶A(PKA)和蛋白激酶C(PKC)介导D2 DAR磷酸化和脱敏的能力。将HEK293T细胞用D2 DAR进行瞬时转染,然后用PKA或PKC的细胞内激活剂和抑制剂进行处理。用增加cAMP并激活PKA的试剂处理,对D2 DAR的磷酸化状态没有影响,这表明PKA在HEK293T细胞中不会使D2 DAR磷酸化。相反,用PKC激活剂佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)处理细胞,导致D2 DAR磷酸化增加约3倍。这种磷酸化对PKC具有特异性,因为PMA的作用可被佛波醇12,13 - 二丁酸酯模拟,但不能被4α - 佛波醇12,13 - 二癸酸酯模拟,这两种佛波醇二酯分别是活性和非活性的。PKC抑制剂双吲哚马来酰亚胺II共同处理可完全阻断PMA介导的D2 DAR磷酸化,而与PKCβI共转染则增强该磷酸化。相反,抑制PKC对激动剂促进的磷酸化没有影响,这表明PKC不参与此反应。发现D2 DAR的PKC磷酸化会促进受体脱敏,这表现为抑制cAMP积累的激动剂效力降低。最有趣的是,PKC磷酸化还通过β - 抑制蛋白和发动蛋白依赖性途径促进D2 DAR的内化,这种反应通常与G蛋白偶联受体的PKC磷酸化无关。定点诱变实验确定了受体第三个细胞内环内的两个PKC磷酸化位点结构域。这两个结构域都参与调节D2 DAR的隔离,而只有一个结构域参与受体脱敏。这些结果表明,PKC可介导D2 DAR的磷酸化,导致功能性脱敏和受体内化。